(Senior)Product Specialist - Medical Sales (Pain / CNS)
Viatris Healthcare Hong Kong Limited
Posted today
Quarry Bay
0 year(s) work experience
Double pay / Education allowance / Five-day work week / Medical insurance
Job Highlight
Job Description
Role Description
Responsible for sales activities in assigned therapeutic area. Manage quality and consistency of product and service delivery.
Responsibilities
- Promote key products and services to current and potential clients in Private Sectors.
- Collaborate with customers to create win-win relationship for both parties’ business growth.
- Establish and maintain excellent professional relationships with the key opinion leaders, medical and pharmaceutical professionals.
- Ensure timely and effective implementation of sales and marketing strategies, in turn achieve sales target.
- Maintain effective communication and good working relations with the Sales Manager, teammates, other sales teams and other related departments to ensure smooth operations and synergies.
- Planning work schedules and weekly timetables
- Regularly attending company meetings, technical data presentations and briefings.
Skills
- Excellent communication & presentation skills
- Proficiency in English, Cantonese and Putonghua is a must
- Energetic and open-minded
- Proficient in MS Office applications
Qualifications
- Bachelor’s Degree, science related discipline is preferred
- Sales experience in pharmaceutical industry is preferred
- Candidate with more experiences will be considered as Senior Product Specialist
Benefit and Others
- Double Pay
- Five-day work week
- Life insurance
- Medical insurance
- Education allowance
The information provided will be treated in strict confidence and be used only for consideration of your application for relevant / similar posts within the Group/ Company.
| Job Function | |
| Work Location | Quarry Bay |
| Benefits | Double pay / Education allowance / Five-day work week / Medical insurance |
| Education |
Degree
|
| Skills | Communication |
| Spoken Language | Intermediate Cantonese / Intermediate English / Intermediate Mandarin |
| Written Language | Intermediate Chinese / Intermediate English / Intermediate Japanese |
| Employment Type | Full Time |
| Industry | Medical / Pharmaceutical |
About company
Viatris Healthcare Hong Kong Limited
About Viatris
(combination of Mylan and Pfizer Upjohn)
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway™.
Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.
Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products.
With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
(combination of Mylan and Pfizer Upjohn)
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway™.
Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.
Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products.
With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.